Cramer vets biotech giants Biogen, Celgene, Gilead and Regeneron for positive prospects
May 10, 2018 at 18:31 PM EDT
Jim Cramer examines "the four horsemen of biotech" to see if their weakening stocks can regain momentum.
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.